Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nasdaq Biotechnology Ishares ETF (NQ: IBB ) 134.08 -1.59 (-1.17%) Official Closing Price Updated: 4:15 PM EDT, May 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Nasdaq Biotechnology Ishares ETF Will the Biotech Sector Shift From Lagger to Leader? May 10, 2024 The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs. Via MarketBeat Topics ETFs Biotech Sector Nears Breakout: Will it Outperform in Q2? April 03, 2024 The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains Via MarketBeat Topics ETFs Will the Biotech sector sustain its momentum in 2024? January 04, 2024 The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%. Via MarketBeat Topics ETFs MarketBeat Week in Review – 12/4 - 12/8 December 09, 2023 Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week Via MarketBeat Topics Economy Exposures Interest Rates 3 biotech powerhouses poised to thrive amid sector rebound December 08, 2023 If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader. Via MarketBeat Topics ETFs Biotech reversal confirmed: what's ahead for the IBB? December 08, 2023 The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum. Via MarketBeat Topics ETFs 3 Strong Biotech Performers To Watch As Sector Nears Breakout August 17, 2023 As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming. Via MarketBeat Topics ETFs Moderna: Declining Performance And Relative Weakness June 30, 2023 Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. Via MarketBeat Topics ETFs Exposures COVID-19 Is the Biotech Industry (IBB) Poised For A Major Breakout? June 12, 2023 The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. Via MarketBeat Topics ETFs Tarsus Added to NASDAQ Biotechnology Index December 16, 2022 From Tarsus Pharmaceuticals, Inc Via GlobeNewswire BriaCell’s Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients December 02, 2022 The world of biotech is having what some are calling a golden age. Many companies are presenting new and innovative drugs to the FDA for approval and later the public for consumption. Smart Beta EFTs... Via TheNewswire.com Topics Stocks Exposures Product Safety US Equities BlackRock Announces Product Updates to Two iShares ETFs April 22, 2021 From BlackRock, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.